Paradigm Biopharmaceuticals Limited (ASX:PAR)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Pharmaceutical Drugs	65.80K
Pharmaceutical Drugs Growth	40.72%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Australia	65.80K
Australia Growth	40.72%